Pathophysiology of renal calcium handling in acromegaly: What lies behind hypercalciuria?

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 2124-2133

  Kamenický, Peter ^a,b,c   Blanchard, Anne ^d,e   Gauci, Cédric ^d   Salenave, Sylvie ^a,b   Letierce, Alexia ^a   Lombès, Marc ^a,b,c   Brailly Tabard, Sylvie ^a,b,c   Azizi, Michel ^d,e   Prié, Dominique ^c,e,f   Souberbielle, Jean Claude ^c,e,f   Chanson, Philippe ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; FUROSEMIDE; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; SODIUM; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM METABOLISM; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE URINE LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; HYPERCALCIURIA; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; MAGNESIUM EXCRETION; MAGNESIUM METABOLISM; MALE; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RENAL CALCIUM HANDLING; RENAL SYSTEM PARAMETERS; SEQUENTIAL ANALYSIS; SINGLE DRUG DOSE; SODIUM EXCRETION; URINARY EXCRETION;

ACROMEGALY; ADULT; AGED; CALCITRIOL; CALCIUM, DIETARY; DIURETICS; FEMALE; FIBROBLAST GROWTH FACTORS; FUROSEMIDE; HUMAN GROWTH HORMONE; HUMANS; HYPERCALCIURIA; INSULIN-LIKE GROWTH FACTOR I; KIDNEY TUBULES, DISTAL; MAGNESIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; SERUM ALBUMIN; SODIUM CHLORIDE, DIETARY; VITAMIN D;

EID: 84861985362     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3188     Document Type: Article

References (46)

1. Menaa C, Vrtovsnik F, Friedlander G, Corvol M, Garabédian M 1995 Insulin-like growth factor I, a unique calcium-dependent stimulator of 1,25-dihydroxyvitamin D3 production. Studies in cultured mouse kidney cells. J Biol Chem 270:25461-25467
2. Nesbitt T, Drezner MK 1993 Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. Endocrinology 132:133-138 (Pubitemid 23019493)
3. Spanos E, Barrett D, MacIntyre I, Pike JW, Safilian EF, Haussler MR 1978 Effect of growth hormone on vitamin D metabolism. Nature 273:246-247 (Pubitemid 8331721)
4. Corvilain J, Abramow M, Bergans A 1962 Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man. J Clin Invest 41:1230-1235
5. Quigley R, Baum M 1991 Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88:368-374
6. Nadarajah A, Hartog M, Redfern B, Thalassinos N, Wright AD, Joplin GF, Fraser TR 1968 Calcium metabolism in acromegaly. Br Med J 4:797-801
7. Takamoto S, Tsuchiya H, Onishi T, Morimoto S, Imanaka S, Mori S, Seino Y, Uozumi T, Kumahara Y 1985 Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J Clin Endocrinol Metab 61:7-11 (Pubitemid 15046186)
8. Melmed S 2006 Medical progress: acromegaly. N Engl J Med 355:2558-2573
9. Ezzat S, Melmed S, Endres D, Eyre DR, Singer FR 1993 Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 76:1452-1457 (Pubitemid 23164360)
10. Fredstorp L, Pernow Y, Werner S 1993 The short and long-term effects of octreotide on calcium homeostasis in patients with acromegaly. Clin Endocrinol (Oxf) 39:331-336 (Pubitemid 23274432)
11. Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ 2003 Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab 88:5650-5655 (Pubitemid 38033029)
12. White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP 2006 Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid targetorgan sensitivity. J Clin Endocrinol Metab 91:913-919 (Pubitemid 43357758)
13. Sigurdsson G, Nunziata V, Reiner M, Nadarajah A, Joplin GF 1973 Calcium absorption and excretion in the gut in acromegaly. Clin Endocrinol (Oxf) 2:187-192
14. Ikkos D, Ljunggren H, Luft R 1956 Glomerular filtration rate and renal plasma flow in acromegaly. Acta Endocrinol (Copenh) 21:226-236
15. Kamenicky P, Blanchard A, Frank M, Salenave S, Letierce A, Azizi M, Lombès M, Chanson P 2011 Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity. J Clin Endocrinol Metab 96:2127-2135
16. Peacock M 1991 Calcium absorption efficiency and calcium requirements in children and adolescents. Am J Clin Nutr 54:261S-265S
17. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-3148
18. Blanchard A, Azizi M, Peyrard S, Stern N, Alhenc-Gelas F, Houillier P, Jeunemaitre X 2007 Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling. Clin J AmSoc Nephrol 2:320-325
19. Gauci C, Moranne O, Fouqueray B, de la Faille R, Maruani G, Haymann JP, Jacquot C, Boffa JJ, Flamant M, Rossert J, Urena P, Stengel B, Souberbielle JC, Froissart M, Houillier P 2008 Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol 19:1592-1598
20. Kamenicky P, Dos Santos C, Espinosa C, Salenave S, Galland F, Le Bouc Y, Maison P, Bougnères P, Chanson P 2009 D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. Eur J Endocrinol 161:231-235
21. Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P 2001 Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59:2206-2215 (Pubitemid 32467613)
22. Walton RJ, Bijvoet OL 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309-310
23. Chanson P, Timsit J, Masquet C, Warnet A, Guillausseau PJ, Birman P, Harris AG, Lubetzki J 1990 Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 113:921-925
24. Breslau NA, McGuire JL, Zerwekh JE, Pak CY 1982 The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab 55:369-373 (Pubitemid 13238744)
25. Taylor EN, Curhan GC 2009 Demographic, dietary, and urinary factors and 24-h urinary calcium excretion. Clin J Am Soc Nephrol 4:1980-1987
26. Houillier P, Normand M, Froissart M, Blanchard A, Jungers P, Paillard M 1996 Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers. Kidney Int 50:987-997 (Pubitemid 26302689)
27. Cappelli C, Gandossi E, Agosti B, Cerudelli B, Cumetti D, Castellano M, Pirola I, De Martino E, Rosei EA 2004 Long-term treatment of acromegaly with lanreotide: evidence of increased serum parathormone concentration. Endocr J 51:517-520 (Pubitemid 40209017)
28. Hai N, Aoki N, Shimatsu A, Mori T, Kosugi S 2000 Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol (Oxf) 52:509-518 (Pubitemid 30249820)
29. Ahmad AM, Hopkins MT, Thomas J, Durham BH, Fraser WD, Vora JP 2004 Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement.AmJ Physiol Endocrinol Metab 286:E986-E993 (Pubitemid 38668823)
30. White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP 2005 Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormonedeficient patients. J Clin Endocrinol Metab 90:3371-3380 (Pubitemid 41014300)
31. Brown DJ, Spanos E, MacIntyre I 1980 Role of pituitary hormones in regulating renal vitamin D metabolism in man. Br Med J 280:277-278 (Pubitemid 10213078)
32. Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CY 1980 Effect of growth hormone administration: reciprocal changes in serum 1 α,25- dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol Metab 51:321-324 (Pubitemid 10007642)
33. Suzuki Y, Landowski CP, Hediger MA 2008 Mechanisms and regulation of epithelial Ca2+ absorption in health and disease. Annu Rev Physiol 70:257-271 (Pubitemid 351738180)
34. Hoenderop JG, Nilius B, Bindels RJ 2005 Calcium absorption across epithelia. Physiol Rev 85:373-422 (Pubitemid 40171261)
35. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA 2001 Magnesium transport in the renal distal convoluted tubule. Physiol Rev 81:51-84 (Pubitemid 32096173)
36. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
37. Quarles LD 2008 Endocrine functions of bone in mineral metabolism regulation. J Clin Invest 118:3820-3828
38. Ito N, Fukumoto S, Taguchi M, Takeshita A, Takeuchi Y, Yamada S, Fujita T 2007 Fibroblast growth factor (FGF)23 in patients with acromegaly. Endocr J 54:481-484 (Pubitemid 47105439)
39. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774 (Pubitemid 44949607)
40. Walker JL, Ginalska-Malinowska M, Romer TE, Pucilowska JB, Underwood LE 1991 Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 324:1483-1488
41. Neggers SJ, Kopchick JJ, Jørgensen JO, van der Lely AJ 2011 Hypothesis: extra-hepatic acromegaly: a new paradigm? Eur J Endocrinol 164:11-16
42. Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA 1999 Inhibitory effect of a growth hormone receptor antagonist (G120KPEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 48:377-382 (Pubitemid 29061114)
43. Dick IM, Devine A, Beilby J, Prince RL 2005 Effects of endogenous estrogen on renal calcium and phosphate handling in elderlywomen. Am J Physiol Endocrinol Metab 288:E430-E435 (Pubitemid 40110653)
44. Prince RL 1994 Counterpoint: estrogen effects on calcitropic hormones and calcium homeostasis. Endocr Rev 15:301-309
45. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS 2005 Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154-164 (Pubitemid 40096612)
46. Holly JM, Cotterill AM, Jemmott RC, Shears D, al-Othman S, Chard T, Wass JA 1991 Inter-relations between growth hormone, insulin, insulin-like growth factor-I (IGF-I), IGF-binding protein-1 (IGFBP-1) and sex hormone-binding globulin in acromegaly. Clin Endocrinol (Oxf) 34:275-280